Dose reduction of risperidone and olanzapine and estimated dopamine D2 receptor occupancy in stable patients with schizophrenia: Findings from an open-label, randomized, controlled study

Hiroyoshi Takeuchi, Takefumi Suzuki, Robert R. Bies, Gary Remington, Koichiro Watanabe, Masaru Mimura, Hiroyuki Uchida

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose reduction of risperidone and olanzapine and estimated dopamine D<sub>2</sub> receptor occupancy in stable patients with schizophrenia: Findings from an open-label, randomized, controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences